Kingdon Capital Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-136,306	Closed	-$16.2M	–	118
2022 Q1	$16.2M	Sell	136,306 -164,067	-55%	-$20.5M	2.75%	17
2021 Q4	$41.4M	Sell	300,373 -65,000	-18%	-$8.27M	6.2%	4
2021 Q3	$50.8M	Sell	365,373 -35,633	-9%	-$4.45M	8.9%	3
2021 Q2	$38.9M	Sell	401,006 -459,255	-53%	-$37.3M	5.94%	5
2021 Q1	$58.8M	Sell	860,261 -370,000	-30%	-$29.9M	9.31%	4
2020 Q4	$105M	Sell	1,230,261 -80,000	-6%	-$6.78M	16.74%	1
2020 Q3	$85.2M	Buy	1,310,261 +8,000	+0.6%	+$524K	12.27%	1
2020 Q2	$95.2M	Sell	1,302,261 -160,500	-11%	-$8.54M	14.11%	4
2020 Q1	$49.8M	Buy	1,462,761 +205,041	+16%	+$9.38M	9.83%	1
2019 Q4	$68.5M	Buy	1,257,720 +100,946	+9%	+$5M	12.86%	1
2019 Q3	$48.3M	Buy	1,156,774 +155,364	+16%	+$6.56M	7.29%	2
2019 Q2	$43.9M	Buy	1,001,410 +157,144	+19%	+$8.86M	5.71%	3
2019 Q1	$43.5M	Buy	844,266 +173,528	+26%	+$7.5M	6.17%	1
2018 Q4	$24.8M	Buy	670,738 +48,410	+8%	+$1.75M	4.32%	8
2018 Q3	$23.4M	Buy	622,328 +24,732	+4%	+$910K	2.17%	18
2018 Q2	$23.6M	Buy	597,596 +81,859	+16%	+$2.6M	2.03%	16
2018 Q1	$13.3M	Buy	+515,737	New	+$15.4M	1.15%	31